KERYX BIOPHARMACEUTICALS INC

CUSIP: 492515101 Class: COMMON STOCK

Swiss National Bank's Holding History (CIK: 0001582202)

Note: Option positions (PUT/CALL) are excluded.

Q3 2018
Shares 160,600 Value ($000) $546 Avg Close — Range —
Q2 2018
Shares 160,600 Value ($000) $604 Avg Close — Range —
Q1 2018
Shares 160,600 Value ($000) $657 Avg Close — Range —
Q4 2017
Shares 142,100 Value ($000) $661 Avg Close — Range —
Q3 2017
Shares 130,500 Value ($000) $927 Avg Close — Range —
Q2 2017
Shares 130,500 Value ($000) $944 Avg Close — Range —
Q1 2017
Shares 130,500 Value ($000) $804 Avg Close — Range —
Q4 2016
Shares 130,500 Value ($000) $765 Avg Close — Range —
Q3 2016
Shares 145,400 Value ($000) $772 Avg Close — Range —
Q2 2016
Shares 145,400 Value ($000) $963 Avg Close — Range —
Q1 2016
Shares 176,100 Value ($000) $795 Avg Close — Range —
Q4 2015
Shares 144,200 Value ($000) $728 Avg Close — Range —
Q3 2015
Shares 144,200 Value ($000) $508 Avg Close — Range —
Q2 2015
Shares 126,900 Value ($000) $1,266 Avg Close — Range —
Q1 2015
Shares 110,400 Value ($000) $1,405 Avg Close — Range —
Q4 2014
Shares 99,200 Value ($000) $1,404 Avg Close — Range —
Q3 2014
Shares 97,000 Value ($000) $1,334 Avg Close — Range —
Q2 2014
Shares 97,000 Value ($000) $1,492 Avg Close — Range —
Q1 2014
Shares 97,000 Value ($000) $1,653 Avg Close — Range —
Q4 2013
Shares 69,900 Value ($000) $905 Avg Close — Range —
Q3 2013
Shares 69,900 Value ($000) $706 Avg Close — Range —
Q2 2013
Shares 73,800 Value ($000) $551 Avg Close — Range —